Clinical Trials
Elacestrant vs. SOC in patients with ER+/HER- early breast cancer
Disease Type: Breast
Elacestrant versus Standard Endocrine Therapy in Women and Men with Node -positive, Estrogen Receptor-positive, HER2-negative, Early Breast Cancer with High Risk of Recurrence - A Global, Multicenter, Randomized, Open-label Phase 3 Study (ELEGANT)(STML-ELA-0422)
Locations
Alleghany , Blacksburg , Roanoke , Salem , Wytheville